| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dicerna Pharmaceuticals Inc | Chief Strategy Officer | Common Stock | 0 | $38.25 | 28 Dec 2021 | Direct | |
| Dicerna Pharmaceuticals Inc | Chief Strategy Officer | Restricted Stock Units | 0 | 28 Dec 2021 | Direct | ||
| Dicerna Pharmaceuticals Inc | Chief Strategy Officer | Employee Stock Option (Right to Buy) | 0 | 28 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 28 Dec 2021 | 6 | -$566,597 | 4 | Chief Strategy Officer | 29 Dec 2021, 15:19 |
| DRNA | Dicerna Pharmaceuticals Inc | 15 Dec 2021 | 3 | -$47,220 | 4 | Chief Strategy Officer | 17 Dec 2021, 15:18 |
| DRNA | Dicerna Pharmaceuticals Inc | 13 Dec 2021 | 2 | +$199,968 | 4 | Chief Strategy Officer | 14 Dec 2021, 20:02 |
| DRNA | Dicerna Pharmaceuticals Inc | 11 Jun 2021 | 6 | -$641,700 | 4 | Chief Commercial Officer | 15 Jun 2021, 19:19 |